Back to Agenda
Session 1 : Regulatory Overview of Cell and Gene Therapy Field
Session Chair(s)
Youngju Choi, PHD
Director General of Biopharmaceutical & Herbal Medicine Evaluation Department , National Institute of Food & Drug Safety (NIFDS), MFDS, Korea, Republic of
In-sook Park, PHD
Former Director General, Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Caroline Pothet, PHARMD, RPH, RAC
Head of advanced therapies and haemato-oncology, European Medicines Agency, Netherlands
Tamei Elliott, MS
Director, Global Scientific Content, DIA, United States
Yasuhiro Kishioka, PHD
Review Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jianchao Gao, MD
Associate Researcher, Changping Laboratory, China
So-Young Wang
Director, CGT Products Div, Biopharmaceuticals & Herbal Med Evaluation Dept., Ministry of Food & Drug Safety, Korea, Republic of
Meehyun Jung
Executive Director, CTX, Inc., Korea, Republic of
MinYoung Kim
Professor , CHA University School of Medicine , Korea, Republic of
Jungtae Park
Vice Chairman, Korea Biomedicine Industry Association, Korea, Republic of
Have an account?